| |
|
|
| |
VENTILATION AIRWAY CLEARANCE
MONITORING PRODUCTS WEBINARS |
|
| |
|
|
|
|
| |
|
|
|
Dear INSERT NAME,
We hope you had a great summer break despite these unusual times and have picked up the thread again. Many of you attended the 2021 ERS Congress virtually earlier this month, we do hope to meet each other again in person soon, either in early March at JIVD 2022 or at ERS 2022.
We've been working hard behind the scenes to update our educational platform! We are delighted to announce that we have improved the search function as well as the structure at the top of the page in the header this will allow you to find content more easily. Discover the new features here. Thank you to everyone who provided input and comments – we hope you enjoy it.
In recent months, over the holiday period, we've had a great turnout to our educational webinars and received good feedback which is always heart-warming, not only for us but certainly for our speakers. We will continue with our global webinars until the end of this year and have started compiling the webinar program for 2022. View our webinar calendar.
And last but not least we can share the good news that we will be adding specific paediatric content to the platform over the next coming months. We are working with global leading experts to build educational materials focused on the care of our smallest patients. So keep an eye on our site!
Best Wishes,
The Education by Breas Team. |
|
| |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Mechanical insufflation-exsufflation (MI-E) is recommended for subjects of all ages with neuromuscular disorders (NMDs) and weak cough. There is a lack of knowledge on the optimal treatment settings for young children.
|
| |
|
|
|
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
| |
|
| |
|
All our webinars are recorded and published within 2 weeks of the live date. Enter “webinar” in the search to discover them all.
|
| |
|
|
| |
|
|
| |
|
| |
| Discover a Clinical Case on The Use of NIV and HFNT with our Vivo 3. Two treatments combined in one device! |
| |
|
|
|
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
